{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:23:59Z","timestamp":1788305039150,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/iae.0000000000000361","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T10:36:14Z","timestamp":1412850974000},"page":"809-819","source":"Crossref","is-referenced-by-count":16,"title":["TIME PATTERNS OF RECURRENCES AND FACTORS PREDISPOSING FOR A HIGHER RISK OF RECURRENCE OF OCULAR TOXOPLASMOSIS"],"prefix":"10.1097","volume":"35","author":[{"given":"Michael","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Ruppenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias D.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(14)74217-5","article-title":". Changing patterns of uveitis.","volume":"103","author":"Henderly","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"R2-28-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","article-title":". Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group.","volume":"121","author":"McCannel","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R3-28-20210130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/09273948.2012.661115","article-title":"Epidemiology of ocular toxoplasmosis.","volume":"20","author":"Petersen","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"R4-28-20210130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":". Uveitis subtypes in a german interdisciplinary uveitis centeranalysis of 1916 patients.","volume":"36","author":"Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"R5-28-20210130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1969.00990010483005","article-title":"Variations in recurrent active toxoplasmic retinochoroiditis.","volume":"81","author":"Friedmann","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"R6-28-20210130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.","volume":"136","author":"Holland","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R7-28-20210130","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajo.2008.01.023","article-title":". Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis.","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R8-28-20210130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/bjo.2007.123661","article-title":"Recurrence characteristics in European patients with ocular toxoplasmosis.","volume":"92","author":"Garweg","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R9-28-20210130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","article-title":". Ocular toxoplasmosis: clinical features and prognosis of 154 patients.","volume":"109","author":"Bosch-Driessen","year":"2002","journal-title":"Ophthalmology"},{"key":"R10-28-20210130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0950268899002800","article-title":". Incidence of symptomatic toxoplasma eye disease: etiology and public health implications.","volume":"123","author":"Gilbert","year":"1999","journal-title":"Epidemiol Infect"},{"key":"R11-28-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-9394(14)73975-3","article-title":". Ocular toxoplasmosis in human immunodeficiency virus-infected patients.","volume":"114","author":"Cochereau-Massin","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R12-28-20210130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0074-02762009000200031","article-title":"Ocular toxoplasmosis: the influence of patient age.","volume":"104","author":"Holland","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R13-28-20210130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":". The effect of long-term intermittent trimethoprimsulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.","volume":"134","author":"Silveira","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R14-28-20210130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":". Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.","volume":"157","author":"Felix","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R15-28-20210130","first-page":"1","article-title":"Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.","volume":"137","author":"Holland","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R16-28-20210130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00347-005-1223-5","article-title":". Computer-based system for monitoring the course of intraocular inflammation in German.","volume":"102","author":"Bauer","year":"2005","journal-title":"Ophthalmologe"},{"key":"R18-28-20210130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.1995.01100120054009","article-title":". Presumed acquired ocular toxoplasmosis.","volume":"113","author":"Ronday","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R19-28-20210130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(99)00266-4","article-title":". Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection.","volume":"128","author":"Ongkosuwito","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R20-28-20210130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9394(88)90697-6","article-title":". Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome.","volume":"106","author":"Holland","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R21-28-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF02306488","article-title":"Ocular toxoplasmosis in the immunocompromised host.","volume":"13","author":"Holland","year":"1989","journal-title":"Int Ophthalmol"},{"key":"R24-28-20210130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0171-2985(99)80065-5","article-title":"Stage differentiation of the protozoan parasite Toxoplasma gondii.","volume":"201","author":"Bohne","year":"1999","journal-title":"Immunobiology"},{"key":"R25-28-20210130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/S0074-02762009000200027","article-title":"Treating ocular toxoplasmosis: current evidence.","volume":"104","author":"Stanford","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R26-28-20210130","first-page":"192","article-title":"Manifestations and management of ocular toxoplasmosis.","volume":"50","author":"OConnor","year":"1974","journal-title":"Bull N Y Acad Med"},{"key":"R27-28-20210130","first-page":"188","article-title":"Clindamycin in the treatment of human ocular toxoplasmosis.","volume":"12","author":"Tate","year":"1977","journal-title":"Can J Ophthalmol"},{"key":"R28-28-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02306491","article-title":". Therapy of ocular toxoplasmosis.","volume":"13","author":"Rothova","year":"1989","journal-title":"Int Ophthalmol"},{"key":"R29-28-20210130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0002-9394(14)73976-5","article-title":". An unusually high prevalence of ocular toxoplasmosis in southern Brazil.","volume":"114","author":"Glasner","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R30-28-20210130","first-page":"23S","article-title":". The status of infection with Toxoplasma gondii in the Swiss population: contribution of a seroepidemiologic study from the Zurich canton in German.","volume":"65","author":"Jacquier","year":"1995","journal-title":"Schweiz Med Wochenschr Suppl"},{"key":"R31-28-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/154.4.357","article-title":". Toxoplasma gondii infection in the United States: seroprevalence and risk factors.","volume":"154","author":"Jones","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R32-28-20210130","first-page":"65","article-title":"Epidemiology of toxoplasmosis in the U.K..","volume":"84","author":"Joynson","year":"1992","journal-title":"Scand J Infect Dis Suppl"},{"key":"R33-28-20210130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2334-11-348","article-title":"Incidence of maternal toxoplasma infections in pregnancy in Upper Austria, 2000-2007.","volume":"11","author":"Sagel","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R34-28-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4269\/ajtmh.1988.38.315","article-title":"Toxoplasmosis in Panama: a 10-year study.","volume":"38","author":"Sousa","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"R35-28-20210130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9394(14)76638-3","article-title":". Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families.","volume":"106","author":"Silveira","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R36-28-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis.","volume":"134","author":"Holland","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R37-28-20210130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":". Therapy for ocular toxoplasmosis.","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:05:55Z","timestamp":1620954355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201504000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000361","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}